Gut Permeability as a Shared Mechanism
Celiac disease requires three factors: genetic susceptibility (HLA-DQ2/DQ8), dietary gluten, and intestinal permeability that allows gluten peptides to access the submucosal immune system. PFAS increase intestinal permeability by disrupting tight junction proteins including occludin and zonulin, potentially providing the environmental trigger that initiates the autoimmune response in genetically susceptible individuals.
PFAS also alter intestinal goblet cell function, reducing mucus layer thickness that normally prevents direct contact between luminal contents and intestinal epithelial cells. A thinner mucus barrier facilitates gluten peptide access to the lamina propria, where the adaptive immune response that destroys intestinal villi is triggered.
Research Evidence
Epidemiological studies examining celiac disease rates in communities with PFAS-contaminated water are limited, but laboratory evidence is compelling. Animal studies show that PFAS pre-treatment followed by gluten challenge produces more severe intestinal inflammation than gluten alone in susceptible rodent models, suggesting PFAS acts as an environmental facilitator.
Human studies have found higher PFAS serum levels in patients with active celiac disease compared to those in remission and to healthy controls. Whether elevated PFAS reflects a cause or consequence of intestinal permeability changes is unclear, as increased gut permeability from celiac disease itself could alter PFAS absorption.
Clinical Considerations
Gastroenterologists evaluating patients with suspected celiac disease or refractory symptoms despite strict gluten avoidance may benefit from assessing PFAS exposure as a contributing factor. In regions with PFAS-contaminated water, celiac disease patients may face an ongoing trigger for intestinal permeability that undermines mucosal healing despite dietary compliance.
Using PFAS-free filtered water for cooking and drinking — eliminating a primary exposure source — may support intestinal barrier recovery. This recommendation aligns with the general principle of environmental trigger reduction in managing autoimmune gastrointestinal conditions.